Literature DB >> 6460946

Abnormal regulation of IgG production in multiple sclerosis.

J M Goust, E L Hogan, P Arnaud.   

Abstract

After stimulation with pokeweed mitogen (PWM), peripheral blood mononuclear cells (MNC) from patients with active multiple sclerosis (MS) produced significantly more IgG (8595 ng per milliliter, p less than 0.01) then MNC from normal age-matched controls (5477 ng per milliliter), whereas those tested during stable periods produced less IgG (4076 ng per milliliter, p less than 0.01). Treatment of MNC with sodium periodate (SP) generated suppressor cells for PWM-driven IgG production in normal controls and in most of the stable MS patients but in only 26% of those during active disease, in whom an increase in IgG production was often seen. This suggests a deficiency of inducible suppressor T cells associated with a supranormal B-cell response to polyclonal activation; T lymphocytes obtained from MS patients during active episodes strongly suppressed IgG production by normal B lymphocytes, whereas their B cells often produced more IgG in the presence of normal T cells. In active MS, a relative B-cell unresponsiveness to activated suppressor T cells would leave helper signals unbalanced, thus leading to increased B-cell activation, which might deplete the pool of inducible suppressor cells for IgG production.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6460946     DOI: 10.1212/wnl.32.3.228

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Defective autologous mixed lymphocyte reactivity in multiple sclerosis.

Authors:  R L Hirsch
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

Review 2.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

Authors:  P J Hughes; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

4.  Spinal fluid lymphocytes responsive to autologous and allogeneic cells in multiple sclerosis and control individuals.

Authors:  G Birnbaum; L Kotilinek; M Schwartz; M Sternad
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis.

Authors:  A Henriksson; S Kam-Hansen; H Link
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

6.  Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain.

Authors:  J P Salier; P Glynn; J M Goust; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

7.  Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.

Authors:  J P Salier; R Sesboüé; C Martin-Mondière; M Daveau; P Cesaro; B Cavelier; A Coquerel; L Legrand; J M Goust; J D Degos
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

8.  Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.

Authors:  M R O'Gorman; J Oger; L F Kastrukoff
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

9.  Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro.

Authors:  R L Hirsch; H S Panitch; K P Johnson
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

Review 10.  Multiple sclerosis: basic concepts and hypothesis.

Authors:  M Rodriguez
Journal:  Mayo Clin Proc       Date:  1989-05       Impact factor: 7.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.